Stock Screener
Stock Research
Market Indexes
Precious Metals
Energy
Commodities
Interest Rates
Economy
Global Metrics

Amarin - 32 Year Stock Price History | AMRN

Historical daily share price chart and data for Amarin since 1993 adjusted for splits and dividends. The latest closing stock price for Amarin as of June 03, 2025 is 11.95.
  • The all-time high Amarin stock closing price was 27500.00 on July 09, 1993.
  • The Amarin 52-week high stock price is 16.60, which is 38.9% above the current share price.
  • The Amarin 52-week low stock price is 7.08, which is 40.8% below the current share price.
  • The average Amarin stock price for the last 52 weeks is 11.51.
For more information on how our historical price data is adjusted see the Stock Price Adjustment Guide.
  
Amarin Historical Annual Stock Price Data
Year Average Stock Price Year Open Year High Year Low Year Close Annual % Change
2025 10.4330 10.4720 12.7040 8.0020 11.9500 23.20%
2024 15.5530 17.7840 27.0000 8.8720 9.7000 -44.25%
2023 24.4838 23.8000 43.8000 13.2000 17.4000 -28.10%
2022 39.8223 70.2000 74.6000 21.4000 24.2000 -64.09%
2021 103.0901 100.6000 176.0000 64.8000 67.4000 -31.08%
2020 170.3802 430.6000 430.6000 72.8000 97.8000 -77.19%
2019 364.1571 260.2000 482.4000 252.2000 428.8000 57.53%
2018 144.3048 84.8000 459.6000 49.0000 272.2000 239.40%
2017 66.3661 61.8000 85.8000 57.4000 80.2000 30.19%
2016 46.8516 36.2000 69.4000 25.4000 61.6000 62.96%
2015 40.1429 22.6000 58.0000 20.0000 37.8000 92.92%
2014 30.3917 39.2000 48.0000 16.6460 19.5940 -50.27%
2013 118.2469 162.0000 183.2000 28.0000 39.4000 -75.65%
2012 221.6366 141.0000 309.2000 127.0000 161.8000 8.01%
2011 214.0792 166.6000 390.0000 120.6000 149.8000 -8.67%
2010 53.0791 27.6000 169.8000 19.6000 164.0200 473.54%
2009 23.8716 13.6000 39.0020 10.4000 28.5980 101.39%
2008 38.1171 50.0000 71.7980 12.0000 14.2000 -72.69%
2007 200.1849 436.0000 756.0000 45.0000 52.0000 -88.60%
2006 522.9477 270.0000 748.0000 254.0000 456.0000 90.00%
2005 358.4254 524.0000 680.8000 212.0000 240.0000 -55.72%
2004 277.9263 308.0000 798.0000 106.0000 542.0000 75.97%
2003 580.3368 788.0000 962.0000 278.0000 308.0000 -61.40%
2002 1685.8640 3420.0000 4200.0000 552.0000 798.0000 -77.04%
2001 2692.2460 1100.0000 5594.0000 1000.0000 3475.0000 215.91%
2000 1204.0249 900.0000 1556.2500 750.0000 1100.0000 15.79%
1999 1428.2570 887.5000 2275.0000 825.0000 950.0000 33.33%
1998 2096.1660 6125.0000 6125.0000 200.0000 712.5000 -88.60%
1997 10031.1192 11625.0000 13250.0000 5875.0000 6250.0000 -46.24%
1996 17057.8657 18000.0000 22500.0000 11000.0000 11625.0000 -35.42%
1995 14767.8167 13500.0000 20000.0000 10000.0000 18000.0000 38.46%
1994 15496.5475 17500.0000 21000.0000 9625.0000 13000.0000 -25.71%
Sector Industry Market Cap Revenue
Medical Medical - Biomedical and Genetics $0.243B $0.229B
Amarin Corporation plc is a commercial-stage pharmaceutical company focused on developing therapies, especially based on omega-3 fatty acid for treating cardiovascular diseases. The company's sole marketed drug, Vascepa (icosapent ethyl) is approved in the United States as an adjunct to diet for treating severe hypertriglyceridemia or elevated triglyceride levels. The FDA approved Vascepa to reduce cardiovascular risk in patients with persistent elevated triglycerides on statin therapy for LDL-C. The drug received approval for both indications in Europe under the tradename of Vazkepa. It has initiated various promotional activities and direct-to-consumer programs as well as expanded its salesforce to support promotion of Vascepa's expanded label. A generic version of Vascepa has been launched for elevated TG levels.
Stock Name Country Market Cap PE Ratio
AstraZeneca (AZN) United Kingdom $223.075B 16.65
Amgen (AMGN) United States $155.112B 13.90
Gilead Sciences (GILD) United States $135.476B 14.07
Vertex Pharmaceuticals (VRTX) United States $114.385B 0.00
Bristol Myers Squibb (BMY) United States $99.292B 6.65
GSK (GSK) United Kingdom $85.954B 10.21
CSL (CSLLY) Australia $78.442B 0.00
Regeneron Pharmaceuticals (REGN) United States $52.991B 12.86
Alnylam Pharmaceuticals (ALNY) United States $39.911B 0.00
Argenex SE (ARGX) Netherlands $35.696B 97.43
BeiGene (ONC) Cayman Islands $29.113B 0.00
BioNTech SE (BNTX) Germany $27.188B 0.00
Biogen (BIIB) United States $19.216B 8.29
Royalty Pharma (RPRX) United States $18.700B 7.90
Genmab (GMAB) Denmark $13.959B 15.66
Genmab (GNMSF) Denmark $13.727B 14.04
Insmed (INSM) United States $13.056B 0.00
Illumina (ILMN) United States $12.837B 24.35
Incyte (INCY) United States $12.642B 96.04
Exelixis (EXEL) United States $11.694B 19.85
BioMarin Pharmaceutical (BMRN) United States $10.941B 17.77
Swedish Orphan Biovitrum (BIOVF) Sweden $10.783B 27.54
Ascendis Pharma (ASND) Denmark $10.712B 0.00
Exact Sciences (EXAS) United States $10.588B 0.00
Moderna (MRNA) United States $10.461B 0.00
QIAGEN (QGEN) Netherlands $9.981B 19.42
Regencell Bioscience Holdings (RGC) Hong Kong, SAR China $9.733B 0.00
Blueprint Medicines (BPMC) United States $8.253B 0.00
Roivant Sciences (ROIV) United Kingdom $7.970B 0.00
Bio-Techne Corp (TECH) United States $7.620B 28.43
Revolution Medicines (RVMD) United States $7.572B 0.00
Verona Pharma American Depositary Share (VRNA) United Kingdom $7.160B 0.00
Halozyme Therapeutics (HALO) United States $6.856B 13.12
Bio-Rad Laboratories (BIO.B) United States $6.805B 23.68
Jazz Pharmaceuticals (JAZZ) Ireland $6.676B 6.43
Repligen (RGEN) United States $6.662B 74.57
Telix Pharmaceuticals (TLX) Australia $5.683B 0.00
TG Therapeutics (TGTX) United States $5.675B 148.96
Nuvalent (NUVL) United States $5.542B 0.00
Legend Biotech (LEGN) United States $5.388B 0.00
Axsome Therapeutics (AXSM) United States $5.301B 0.00
Guardant Health (GH) United States $5.216B 0.00
Alkermes (ALKS) Ireland $5.160B 13.85
Zealand Pharma (ZLDPF) Denmark $5.005B 0.00
ADMA Biologics Inc (ADMA) United States $4.877B 36.48
Vaxcyte (PCVX) United States $4.518B 0.00
Merus (MRUS) Netherlands $4.051B 0.00
Rhythm Pharmaceuticals (RYTM) United States $4.050B 0.00
Akero Therapeutics (AKRO) United States $4.044B 0.00
Avidity Biosciences (RNA) United States $3.998B 0.00
PTC Therapeutics (PTCT) United States $3.870B 6.74
Cytokinetics (CYTK) United States $3.727B 0.00
Sarepta Therapeutics (SRPT) United States $3.709B 0.00
Krystal Biotech (KRYS) United States $3.623B 27.92
ACADIA Pharmaceuticals (ACAD) United States $3.592B 31.57
SpringWorks Therapeutics (SWTX) United States $3.517B 0.00
Zai Lab (ZLAB) China $3.441B 0.00
Ultragenyx Pharmaceutical (RARE) United States $3.417B 0.00
Arcellx (ACLX) United States $3.413B 0.00
Alvotech (ALVO) Luxembourg $3.381B 19.34
CRISPR Therapeutics AG (CRSP) Switzerland $3.191B 0.00
Protagonist Therapeutics (PTGX) United States $3.108B 66.87
Metsera (MTSR) United States $2.954B 0.00
Viking Therapeutics (VKTX) United States $2.934B 0.00
Scholar Rock Holding (SRRK) United States $2.826B 0.00
Kymera Therapeutics (KYMR) United States $2.809B 0.00
MoonLake Immunotherapeutics (MLTX) Switzerland $2.635B 0.00
Immunovant (IMVT) United States $2.634B 0.00
Apellis Pharmaceuticals (APLS) United States $2.406B 0.00
HUTCHMED (China) (HCM) Hong Kong, SAR China $2.371B 0.00
ImmunityBio (IBRX) United States $2.357B 0.00
Xenon Pharmaceuticals (XENE) Canada $2.307B 0.00
Mirum Pharmaceuticals (MIRM) United States $2.277B 0.00
Arrowhead Pharmaceuticals (ARWR) United States $2.265B 0.00
Ascentage Pharma Group - (AAPG) China $2.197B 0.00
Bavarian Nordic (BVNRY) Denmark $2.176B 11.50
Belite Bio (BLTE) United States $2.070B 0.00
Harmony Biosciences Holdings (HRMY) United States $2.042B 13.57
Kiniksa Pharmaceuticals (KNSA) United Kingdom $2.037B 0.00
Vericel (VCEL) United States $2.037B 1348.67
Denali Therapeutics (DNLI) United States $2.028B 0.00
CG Oncology (CGON) United States $2.027B 0.00
Vera Therapeutics (VERA) United States $2.024B 0.00
Ligand Pharmaceuticals (LGND) United States $1.961B 0.00
Immunocore Holdings (IMCR) United Kingdom $1.942B 0.00
NovoCure (NVCR) Jersey $1.900B 0.00
Amicus Therapeutics (FOLD) United States $1.897B 205.33
Agios Pharmaceuticals (AGIO) United States $1.890B 0.00
Twist Bioscience (TWST) United States $1.861B 0.00
IDEAYA Biosciences (IDYA) United States $1.858B 0.00
Tarsus Pharmaceuticals (TARS) United States $1.842B 0.00
Certara (CERT) United States $1.785B 33.33
Apogee Therapeutics (APGE) United States $1.673B 0.00
Disc Medicine (IRON) United States $1.653B 0.00
Beam Therapeutics (BEAM) United States $1.628B 0.00
Arcutis Biotherapeutics (ARQT) United States $1.607B 0.00
Biohaven (BHVN) United States $1.601B 0.00
Edgewise Therapeutics (EWTX) United States $1.545B 0.00
Janux Therapeutics (JANX) United States $1.480B 0.00
89BIO (ETNB) United States $1.476B 0.00
Adaptive Biotechnologies (ADPT) United States $1.451B 0.00
Liquidia Technologies (LQDA) United States $1.442B 0.00
Travere Therapeutics (TVTX) United States $1.378B 0.00
GRAIL (GRAL) United States $1.349B 0.00
ANI Pharmaceuticals (ANIP) United States $1.341B 13.82
Mesoblast (MESO) Australia $1.326B 0.00
Celldex Therapeutics (CLDX) United States $1.326B 0.00
MannKind (MNKD) United States $1.304B 26.81
BGM Group (BGM) China $1.254B 0.00
Structure Therapeutics (GPCR) United States $1.250B 0.00
Pacira BioSciences (PCRX) United States $1.215B 11.56
Dynavax Technologies (DVAX) United States $1.182B 70.29
Novavax (NVAX) United States $1.145B 2.67
Viridian Therapeutics (VRDN) United States $1.140B 0.00
Anbio Biotechnology (NNNN) Germany $1.139B 0.00
CureVac (CVAC) Germany $1.039B 5.03
Mineralys Therapeutics (MLYS) United States $1.023B 0.00
Arcus Biosciences (RCUS) United States $0.976B 0.00
WAVE Life Sciences (WVE) Singapore $0.963B 0.00
Syndax Pharmaceuticals (SNDX) United States $0.945B 0.00
MiMedx (MDXG) United States $0.944B 22.82
Spyre Therapeutics (SYRE) United States $0.928B 0.00
Nurix Therapeutics (NRIX) United States $0.926B 0.00
Niagen Bioscience (NAGE) United States $0.924B 130.33
NeoGenomics (NEO) United States $0.923B 0.00
Geron (GERN) United States $0.911B 0.00
Pharvaris (PHVS) Netherlands $0.862B 0.00
CorMedix Inc (CRMD) United States $0.861B 57.73
Oculis Holding AG (OCS) Switzerland $0.839B 0.00
LENZ Therapeutics (LENZ) United States $0.821B 0.00
Praxis Precision Medicines (PRAX) United States $0.811B 0.00
Zymeworks (ZYME) United States $0.810B 0.00
Nuvation Bio (NUVB) United States $0.796B 0.00
UniQure (QURE) Netherlands $0.793B 0.00
Immunome (IMNM) United States $0.788B 0.00
Pharming Group (PHAR) Netherlands $0.764B 0.00
ArriVent BioPharma (AVBP) United States $0.753B 0.00
Intellia Therapeutics (NTLA) United States $0.742B 0.00
Replimune (REPL) United States $0.738B 0.00
Immatics (IMTX) Germany $0.731B 0.00
Gyre Therapeutics (GYRE) United States $0.720B 192.00
Day One Biopharmaceuticals (DAWN) United States $0.711B 0.00
Vir Biotechnology (VIR) United States $0.701B 0.00
Pharming Group (PHGUF) Netherlands $0.671B 0.00
Anavex Life Sciences (AVXL) United States $0.645B 0.00
Sinovac Biotech (SVA) China $0.645B 0.00
Arbutus Biopharma (ABUS) United States $0.644B 0.00
AnaptysBio (ANAB) United States $0.642B 0.00
Cogent Biosciences (COGT) United States $0.639B 0.00
AbCellera Biologics (ABCL) Canada $0.639B 0.00
Trevi Therapeutics (TRVI) United States $0.631B 0.00
Basilea Pharmaceutica AG (BPMUF) Switzerland $0.626B 0.00
Sionna Therapeutics (SION) United States $0.616B 0.00
Oric Pharmaceuticals (ORIC) United States $0.602B 0.00
GH Research (GHRS) Ireland $0.601B 0.00
Keros Therapeutics (KROS) United States $0.595B 0.00
Bicycle Therapeutics (BCYC) United Kingdom $0.592B 0.00
Iovance Biotherapeutics (IOVA) United States $0.588B 0.00
Upstream Bio (UPB) United States $0.573B 0.00
Mind Medicine (MindMed) (MNMD) United States $0.565B 0.00
Dianthus Therapeutics (DNTH) United States $0.564B 0.00
Kura Oncology (KURA) United States $0.545B 0.00
Stoke Therapeutics (STOK) United States $0.541B 12.54
Bicara Therapeutics (BCAX) United States $0.540B 0.00
Arvinas (ARVN) United States $0.535B 0.00
Maze Therapeutics (MAZE) United States $0.530B 0.00
Opthea (OPT) Australia $0.525B 0.00
REGENXBIO (RGNX) United States $0.519B 0.00
Cullinan Therapeutics (CGEM) United States $0.516B 0.00
EYEPOINT PHARMACEUTICALS, INC (EYPT) United States $0.511B 0.00
Tyra Biosciences (TYRA) United States $0.510B 0.00
Autolus Therapeutics (AUTL) United Kingdom $0.508B 0.00
Eton Pharmaceuticals (ETON) United States $0.505B 0.00
Sana Biotechnology (SANA) United States $0.496B 0.00
Oxford BioMedica (OXBDF) United Kingdom $0.494B 0.00
Castle Biosciences (CSTL) United States $0.470B 31.90
PureTech Health (PRTC) United States $0.447B 0.00
Septerna (SEPN) United States $0.442B 0.00
Celcuity (CELC) United States $0.440B 0.00
MBX Biosciences (MBX) United States $0.439B 0.00
MeiraGTx Holdings (MGTX) United States $0.439B 0.00
Zhengye Biotechnology Holding (ZYBT) China $0.432B 0.00
Tectonic Therapeutic (TECX) United States $0.430B 0.00
ATyr Pharma (ATYR) United States $0.423B 0.00
Zenas BioPharma (ZBIO) United States $0.421B 0.00
Ginkgo Bioworks Holdings (DNA) United States $0.417B 0.00
Sage Therapeutics (SAGE) United States $0.415B 0.00
Myriad Genetics (MYGN) United States $0.411B 0.00
Humacyte (HUMA) United States $0.406B 0.00
Mereo BioPharma Group - (MREO) United Kingdom $0.405B 0.00
Erasca (ERAS) United States $0.404B 0.00
Abivax SA (ABVX) France $0.403B 0.00
Benitec Biopharma (BNTC) United States $0.400B 0.00
Kamada (KMDA) Israel $0.397B 23.79
Northwest Biotherapeutics (NWBO) United States $0.393B 0.00
Precigen (PGEN) United States $0.393B 0.00
ITeos Therapeutics (ITOS) United States $0.383B 0.00
Fulcrum Therapeutics (FULC) United States $0.376B 0.00
Fortrea Holdings (FTRE) United States $0.374B 10.32
Checkpoint Therapeutics (CKPT) United States $0.371B 0.00
Vigil Neuroscience (VIGL) United States $0.370B 0.00
Rezolute (RZLT) United States $0.361B 0.00
Cytek Biosciences (CTKB) United States $0.358B 0.00
Absci (ABSI) United States $0.348B 0.00
ADC Therapeutics SA (ADCT) Switzerland $0.348B 0.00
Arcturus Therapeutics Holdings (ARCT) United States $0.347B 0.00
Rapport Therapeutics (RAPP) United States $0.343B 0.00
Emergent Biosolutions (EBS) United States $0.342B 0.00
Verastem (VSTM) United States $0.331B 0.00
Inventiva S.A (IVA) France $0.324B 0.00
Phathom Pharmaceuticals (PHAT) United States $0.324B 0.00
Abeona Therapeutics (ABEO) United States $0.321B 0.00
Aura Biosciences (AURA) United States $0.310B 0.00
Entrada Therapeutics (TRDA) United States $0.309B 10.05
Alpha Teknova (TKNO) United States $0.306B 0.00
Olema Pharmaceuticals (OLMA) United States $0.299B 0.00
Compass Therapeutics (CMPX) United States $0.297B 0.00
Rocket Pharmaceuticals (RCKT) United States $0.296B 0.00
XOMA Royalty (XOMA) United States $0.290B 0.00
Terns Pharmaceuticals (TERN) United States $0.286B 0.00
Cidara Therapeutics (CDTX) United States $0.284B 0.00
Candel Therapeutics (CADL) United States $0.280B 0.00
Tvardi Therapeutics (TVRD) United States $0.279B 0.00
Palvella Therapeutics (PVLA) United States $0.278B 0.00
Allogene Therapeutics (ALLO) United States $0.278B 0.00
Monte Rosa Therapeutics (GLUE) United States $0.277B 56.25
Tango Therapeutics (TNGX) United States $0.275B 0.00
Corvus Pharmaceuticals (CRVS) United States $0.275B 0.00
Solid Biosciences (SLDB) United States $0.274B 0.00
Prima BioMed (IMMP) Australia $0.272B 0.00
Astria Therapeutics (ATXS) United States $0.270B 0.00
2seventy Bio (TSVT) United States $0.266B 0.00
Atea Pharmaceuticals (AVIR) United States $0.265B 0.00
Gossamer Bio (GOSS) United States $0.263B 0.00
Cartesian Therapeutics (RNAC) United States $0.259B 0.00
Inozyme Pharma (INZY) United States $0.257B 0.00
Lifecore Biomedical (LFCR) United States $0.254B 0.00
Vanda Pharmaceuticals (VNDA) United States $0.253B 0.00
Neurogene (NGNE) United States $0.253B 0.00
Prothena (PRTA) Ireland $0.251B 0.00
Ocugen (OCGN) United States $0.244B 0.00
Aardvark Therapeutics (AARD) United States $0.241B 0.00
MaxCyte (MXCT) United States $0.240B 0.00
Semper Paratus Acquisition (TVGN) United States $0.237B 0.00
Third Harmonic Bio (THRD) United States $0.236B 0.00
Annexon (ANNX) United States $0.233B 0.00
Foghorn Therapeutics (FHTX) United States $0.232B 0.00
ACELYRIN, INC (SLRN) United States $0.229B 0.00
Design Therapeutics (DSGN) United States $0.228B 0.00
Lexicon Pharmaceuticals (LXRX) United States $0.225B 0.00
Urogen Pharma (URGN) United States $0.223B 0.00
Cardiff Oncology (CRDF) United States $0.223B 0.00
Adherex Technologies (FENC) United States $0.219B 0.00
Y-mAbs Therapeutics (YMAB) United States $0.215B 0.00
GENFIT S.A (GNFT) France $0.214B 0.00
Adocia (ADOCY) France $0.213B 0.00
DBV Technologies S.A (DBVT) France $0.212B 0.00
Actuate Therapeutics (ACTU) United States $0.208B 0.00
EnGene Holdings (ENGN) Canada $0.203B 0.00
ScPharmaceuticals (SCPH) United States $0.203B 0.00
CytomX Therapeutics (CTMX) United States $0.202B 5.23
Bright Minds Biosciences (DRUG) United States $0.199B 0.00
Innate Pharma S.A (IPHA) France $0.199B 0.00
CARGO Therapeutics (CRGX) United States $0.197B 0.00
Instil Bio (TIL) United States $0.194B 0.00
Kodiak Sciences (KOD) United States $0.190B 0.00
Nuvectis Pharma (NVCT) United States $0.188B 0.00
Inhibrx Biosciences (INBX) United States $0.188B 0.11
ProQR Therapeutics (PRQR) Netherlands $0.187B 0.00
Codexis (CDXS) United States $0.186B 0.00
Monopar Therapeutics (MNPR) United States $0.184B 0.00
Eledon Pharmaceuticals (ELDN) United States $0.183B 0.00
Voyager Therapeutics (VYGR) United States $0.182B 0.00
DiaMedica Therapeutics (DMAC) United States $0.179B 0.00
BioStem Technologies (BSEM) $0.179B 7.28
Tiziana Life Sciences (TLSA) United Kingdom $0.168B 0.00
INmune Bio (INMB) United States $0.165B 0.00
AC Immune (ACIU) Switzerland $0.165B 0.00
Anika Therapeutics (ANIK) United States $0.164B 0.00
Puma Biotechnology (PBYI) United States $0.163B 4.27
Galena Biopharma (SLS) United States $0.158B 0.00
Prime Medicine (PRME) United States $0.156B 0.00
Alpha Cognition (ACOG) Canada $0.156B 0.00
Alumis (ALMS) United States $0.155B 0.00
Spero Therapeutics (SPRO) United States $0.153B 0.00
Molecular Partners AG (MOLN) Switzerland $0.153B 0.00
Fate Therapeutics (FATE) United States $0.149B 0.00
Editas Medicine (EDIT) United States $0.148B 0.00
BioAge Labs (BIOA) United States $0.145B 0.00
Ventyx Biosciences (VTYX) United States $0.145B 0.00
Eupraxia Pharmaceuticals (EPRX) Canada $0.141B 0.00
Alector (ALEC) United States $0.138B 0.00
TuHURA Biosciences (HURA) United States $0.136B 0.00
Black Diamond Therapeutics (BDTX) United States $0.135B 39.50
Compugen (CGEN) Israel $0.134B 0.00
Greenwich LifeSciences (GLSI) United States $0.129B 0.00
Seer (SEER) United States $0.126B 0.00
Rapt Therapeutics (RAPT) United States $0.124B 0.00
Elicio Therapeutics (ELTX) United States $0.124B 0.00
Nkarta (NKTX) United States $0.123B 0.00
Orchestra BioMed Holdings (OBIO) United States $0.121B 0.00
Neumora Therapeutics (NMRA) United States $0.121B 0.00
Theratechnologies (THTX) Canada $0.119B 0.00
Contineum Therapeutics (CTNM) United States $0.115B 0.00
Kyverna Therapeutics (KYTX) United States $0.115B 0.00
Agenus (AGEN) United States $0.113B 0.00
EXoZymes (EXOZ) United States $0.113B 0.00
Prenetics Global (PRE) Hong Kong, SAR China $0.112B 0.00
Invivyd (IVVD) United States $0.112B 0.00
BioHarvest Sciences (BHST) Canada $0.111B 0.00
Sangamo Therapeutics (SGMO) United States $0.110B 0.00
Sagimet Biosciences (SGMT) United States $0.107B 0.00
IO Biotech (IOBT) Denmark $0.107B 0.00
Cabaletta Bio (CABA) United States $0.105B 0.00
I-Mab (IMAB) United States $0.105B 0.00
23andMe Holding (MEHCQ) United States $0.101B 0.00
Cuprina Holdings (Cayman) (CUPR) Singapore $0.099B 0.00
Adagene (ADAG) China $0.098B 0.00
HilleVax (HLVX) United States $0.097B 0.00
C4 Therapeutics (CCCC) United States $0.094B 0.00
ANIXA BIOSCIENCES INC (ANIX) United States $0.093B 0.00
Coya Therapeutics (COYA) United States $0.093B 0.00
Milestone Pharmaceuticals (MIST) Canada $0.092B 0.00
Genelux (GNLX) United States $0.092B 0.00
Nautilus Biotechnology (NAUT) United States $0.092B 0.00
Zentalis Pharmaceuticals (ZNTL) United States $0.092B 0.00
Caribou Biosciences (CRBU) United States $0.091B 0.00
Coherus BioSciences (CHRS) United States $0.089B 0.00
Pliant Therapeutics (PLRX) United States $0.088B 0.00
Entera Bio (ENTX) Israel $0.088B 0.00
XBiotech (XBIT) United States $0.087B 0.00
Cellectis S.A (CLLS) France $0.083B 0.00
TScan Therapeutics (TCRX) United States $0.083B 0.00
Genenta Science S.p.A (GNTA) Italy $0.082B 0.00
Whitehawk Therapeutics (WHWK) United States $0.082B 0.00
Jasper Therapeutics (JSPR) United States $0.082B 0.00
Senti Biosciences (SNTI) United States $0.081B 0.00
Climb Bio (CLYM) United States $0.080B 0.00
Inovio Pharmaceuticals (INO) United States $0.077B 0.00
Sutro Biopharma (STRO) United States $0.076B 0.00
Adaptimmune Therapeutics (ADAP) United Kingdom $0.076B 0.00
IGM Biosciences (IGMS) United States $0.075B 0.00
Tenaya Therapeutics (TNYA) United States $0.075B 0.00
Immix Biopharma (IMMX) United States $0.072B 0.00
Elutia (ELUT) United States $0.072B 0.00
CervoMed (CRVO) United States $0.071B 0.00
Alto Neuroscience (ANRO) United States $0.070B 0.00
VistaGen Therapeutics (VTGN) United States $0.070B 0.00
Skye Bioscience (SKYE) United States $0.069B 0.00
MediciNova (MNOV) United States $0.069B 0.00
Zura Bio (ZURA) United States $0.069B 0.00
Immuneering (IMRX) United States $0.067B 0.00
Immunic (IMUX) United States $0.067B 0.00
ZIVO Bioscience (ZIVO) United States $0.067B 0.00
Exicure (XCUR) United States $0.066B 0.00
BeyondSpring (BYSI) United States $0.066B 0.00
Opus Genetics (IRD) United States $0.065B 0.00
PDS Biotechnology (PDSB) United States $0.064B 0.00
Citius Oncology (CTOR) United States $0.064B 0.00
Akoya Biosciences (AKYA) United States $0.062B 0.00
Adicet Bio (ACET) United States $0.062B 0.00
Ikena Oncology (IKNA) United States $0.062B 0.00
Seres Therapeutics (MCRB) United States $0.061B 0.00
Achilles Therapeutics (ACHL) United Kingdom $0.061B 0.00
Acumen Pharmaceuticals (ABOS) United States $0.061B 0.00
Oncobiologics (OTLK) United States $0.059B 0.00
Adlai Nortye (ANL) Cayman Islands $0.059B 0.00
OKYO Pharma (OKYO) $0.059B 0.00
Repare Therapeutics (RPTX) Canada $0.059B 0.00
Biomea Fusion (BMEA) United States $0.058B 0.00
Forte Biosciences (FBRX) United States $0.058B 0.00
Clearside Biomedical (CLSD) United States $0.058B 0.00
TELA Bio (TELA) United States $0.056B 0.00
Kalaris Therapeutics (KLRS) United States $0.056B 0.00
Precision BioSciences (DTIL) United States $0.056B 0.00
Fortress Biotech (FBIO) United States $0.054B 0.00
InflaRx (IFRX) Germany $0.054B 0.00
Werewolf Therapeutics (HOWL) United States $0.054B 0.00
Celularity (CELU) United States $0.054B 0.00
VTv Therapeutics (VTVT) United States $0.053B 0.00
RenovoRx (RNXT) United States $0.052B 0.00
Annovis Bio (ANVS) United States $0.051B 0.00
Adverum Biotechnologies (ADVM) United States $0.051B 0.00
Applied Therapeutics (APLT) United States $0.050B 0.00
Shattuck Labs (STTK) United States $0.050B 0.00
Renovaro (RENB) United States $0.050B 0.00
Cue Biopharma (CUE) United States $0.049B 0.00
Bluebird Bio (BLUE) United States $0.049B 0.00
Quince Therapeutics (QNCX) United States $0.048B 0.00
Atara Biotherapeutics (ATRA) United States $0.048B 0.00
Artiva Biotherapeutics (ARTV) United States $0.047B 0.00
PepGen (PEPG) United States $0.047B 0.00
Mersana Therapeutics (MRSN) United States $0.047B 0.00
Akari Therapeutics (AKTX) United Kingdom $0.046B 0.00
Connect Biopharma Holdings (CNTB) United States $0.046B 0.00
Imunon (IMNN) United States $0.044B 0.00
Clene (CLNN) United States $0.044B 0.00
Anebulo Pharmaceuticals (ANEB) United States $0.043B 0.00
Barinthus Biotherapeutics (BRNS) United Kingdom $0.043B 0.00
Rein Therapeutics (RNTX) United States $0.043B 0.00
Biodexa Pharmaceuticals (BDRX) United Kingdom $0.042B 0.00
Quantum Biopharma (QNTM) Canada $0.041B 0.00
Alterity Therapeutics - (ATHE) Australia $0.041B 0.00
Kronos Bio (KRON) United States $0.041B 0.00
CAMP4 Therapeutics (CAMP) United States $0.040B 0.00
Radiopharm Theranostics - (RADX) Australia $0.039B 0.00
Xilio Therapeutics (XLO) United States $0.036B 0.00
OnKure Therapeutics (OKUR) United States $0.036B 0.00
Medicus Pharma (MDCX) United States $0.036B 0.00
Estrella Immunopharma (ESLA) United States $0.035B 0.00
Pluri (PLUR) Israel $0.035B 0.00
Lantern Pharma (LTRN) United States $0.034B 0.00
Scilex Holding (SCLX) United States $0.034B 0.00
LAVA Therapeutics (LVTX) Netherlands $0.034B 0.00
Coeptis Therapeutics Holdings (COEP) United States $0.033B 0.00
Aligos Therapeutics (ALGS) United States $0.032B 0.00
Rani Therapeutics Holdings (RANI) United States $0.032B 0.00
AN2 Therapeutics (ANTX) United States $0.032B 0.00
Kezar Life Sciences (KZR) United States $0.032B 0.00
Dyadic (DYAI) United States $0.031B 0.00
ALX Oncology Holdings (ALXO) United States $0.030B 0.00
BioAtla (BCAB) United States $0.030B 0.00
Oncolytics Biotech (ONCY) Canada $0.030B 0.00
Allakos (ALLK) United States $0.030B 0.00
Vor Biopharma (VOR) $0.029B 0.00
FibroBiologics (FBLG) United States $0.029B 0.00
MiNK Therapeutics (INKT) United States $0.029B 0.00
Grace Therapeutics (GRCE) Canada $0.028B 0.00
Passage Bio (PASG) United States $0.027B 0.00
Dare Bioscience (DARE) United States $0.027B 0.00
Cadrenal Therapeutics (CVKD) United States $0.027B 0.00
ABVC BioPharma (ABVC) United States $0.026B 0.00
CollPlant Biotechnologies (CLGN) Israel $0.026B 0.00
Generation Bio (GBIO) United States $0.026B 0.00
Curis (CRIS) United States $0.026B 0.00
Chemomab Therapeutics (CMMB) Israel $0.025B 0.00
Boundless Bio (BOLD) United States $0.025B 0.00
Cyclacel Pharmaceuticals (CYCC) $0.025B 0.00
Tenax Therapeutics (TENX) United States $0.025B 0.00
Lisata Therapeutics (LSTA) United States $0.024B 0.00
MIRA Pharmaceuticals (MIRA) United States $0.024B 0.00
NeuroSense Therapeutics (NRSN) Israel $0.023B 0.00
CalciMedica (CALC) United States $0.023B 0.00
KALA BIO (KALA) United States $0.023B 0.00
Femasys (FEMY) United States $0.023B 0.00
Q32 Bio (QTTB) United States $0.022B 0.00
X4 Pharmaceuticals (XFOR) United States $0.022B 0.00
Ovid Therapeutics (OVID) United States $0.021B 0.00
Advanced Biomed (ADVB) United States $0.021B 0.00
Cognition Therapeutics (CGTX) United States $0.020B 0.00
HOOKIPA Pharma (HOOK) United States $0.019B 0.00
Aspire Biopharma Holdings (ASBP) United States $0.019B 0.00
Longeveron (LGVN) United States $0.019B 0.00
Elevation Oncology (ELEV) United States $0.018B 0.00
SAB Biotherapeutics (SABS) United States $0.018B 0.00
Lexaria Bioscience (LEXX) Canada $0.017B 0.00
Cingulate (CING) United States $0.017B 0.00
Promis Neurosciences (PMN) Canada $0.016B 0.00
Beyond Air (XAIR) United States $0.016B 0.00
GeoVax Labs (GOVX) United States $0.016B 0.00
Leap Therapeutics (LPTX) United States $0.015B 0.00
Gelteq (GELS) Australia $0.014B 0.00
Edesa Biotech (EDSA) Canada $0.014B 0.00
Synlogic (SYBX) United States $0.014B 0.00
IBio (IBIO) United States $0.014B 0.00
Biorestorative Therapies (BRTX) United States $0.014B 0.00
Allarity Therapeutics (ALLR) United States $0.013B 0.00
NextCure (NXTC) United States $0.013B 0.00
Abpro Holdings (ABP) United States $0.013B 0.00
Neuphoria Therapeutics (NEUP) Australia $0.013B 0.00
Lipella Pharmaceuticals (LIPO) United States $0.013B 0.00
Equillium (EQ) United States $0.013B 0.00
BRIACELL THERAP (BCTX) Canada $0.013B 0.00
Moleculin Biotech (MBRX) United States $0.013B 0.00
MetaVia (MTVA) United States $0.013B 0.00
Bionano Genomics (BNGO) United States $0.012B 0.00
UNITY Biotechnology (UBX) United States $0.012B 0.00
Hoth Therapeutics (HOTH) United States $0.012B 0.00
IN8bio (INAB) United States $0.012B 0.00
Rallybio (RLYB) United States $0.012B 0.00
Bolt Biotherapeutics (BOLT) United States $0.012B 0.00
BioCardia (BCDA) United States $0.012B 0.00
COSCIENS Biopharma (CSCI) Canada $0.011B 0.00
Athira Pharma (ATHA) United States $0.011B 0.00
Aytu BioPharma (AYTU) United States $0.011B 0.00
Intensity Therapeutics (INTS) United States $0.011B 0.00
HCW Biologics (HCWB) United States $0.010B 0.00
IMMURON (IMRN) Australia $0.010B 0.00
Dogwood Therapeutics (DWTX) United States $0.010B 0.00
Aprea Therapeutics (APRE) United States $0.010B 0.00
LakeShore Biopharma (LSB) China $0.010B 0.00
Cyclerion Therapeutics (CYCN) United States $0.010B 0.00
GENPREX (GNPX) United States $0.009B 0.00
Acurx Pharmaceuticals (ACXP) United States $0.009B 0.00
Brainstorm Cell Therapeutics (BCLI) United States $0.009B 0.00
Silexion Therapeutics Corp (SLXN) Israel $0.008B 0.00
Portage Biotech (PRTG) $0.008B 0.00
BioXcel Therapeutics (BTAI) United States $0.008B 0.00
Sensei Biotherapeutics (SNSE) United States $0.008B 0.00
Cardio Diagnostics Holdings (CDIO) United States $0.007B 0.00
BioAffinity Technologies (BIAF) United States $0.007B 0.00
Turnstone Biologics (TSBX) United States $0.007B 0.00
Apollomics (APLM) United States $0.007B 0.00
Mainz Biomed (MYNZ) Germany $0.007B 0.00
GT Biopharma (GTBP) United States $0.007B 0.00
Pasithea Therapeutics (KTTA) United States $0.007B 0.00
Avalon GloboCare (ALBT) United States $0.007B 0.00
Arcadia Biosciences (RKDA) United States $0.007B 0.00
Sunshine Biopharma (SBFM) United States $0.006B 0.00
Soligenix (SNGX) United States $0.006B 0.00
Jade Biosciences (JBIO) United States $0.006B 0.00
180 Life Sciences (ATNF) United States $0.006B 0.00
Evogene (EVGN) Israel $0.006B 0.00
Mustang Bio (MBIO) United States $0.006B 0.00
Creative Medical Technology Holdings (CELZ) United States $0.006B 0.00
Adial Pharmaceuticals (ADIL) United States $0.006B 0.00
CNS Pharmaceuticals (CNSP) United States $0.005B 0.00
Biofrontera (BFRI) United States $0.005B 0.00
Ensysce Biosciences (ENSC) United States $0.005B 0.00
Onconetix (ONCO) United States $0.005B 0.00
Eyenovia (EYEN) United States $0.005B 0.00
Dermata Therapeutics (DRMA) United States $0.004B 0.00
Titan Pharmaceuticals (TTNP) United States $0.004B 0.00
Galecto (GLTO) Denmark $0.004B 0.00
Polyrizon (PLRZ) Israel $0.004B 0.00
Tharimmune (THAR) United States $0.004B 0.00
Novogen (KZIA) Australia $0.004B 0.00
Lixte Biotechnology Holdings (LIXT) United States $0.004B 0.00
Synaptogenix (SNPX) United States $0.004B 0.00
Sonnet BioTherapeutics Holdings (SONN) United States $0.004B 0.00
Palisade Bio (PALI) United States $0.004B 0.00
Artelo Biosciences (ARTL) United States $0.004B 0.00
Purple Biotech (PPBT) Israel $0.004B 0.00
VivoSim Labs (VIVS) United States $0.003B 0.00
AquaBounty Technologies (AQB) United States $0.003B 0.00
Virax Biolabs Group (VRAX) United Kingdom $0.003B 0.00
ZyVersa Therapeutics (ZVSA) United States $0.003B 0.00
Enveric Biosciences (ENVB) United States $0.003B 0.00
Affimed (AFMD) Germany $0.003B 0.00
Alzamend Neuro (ALZN) United States $0.003B 0.00
Windtree Therapeutics (WINT) United States $0.003B 0.00
GRI Bio (GRI) United States $0.003B 0.00
Bone Biologics (BBLG) United States $0.003B 0.00
Psyence Biomedical (PBM) Canada $0.003B 0.00
Scinai Immunotherapeutics (SCNI) Israel $0.003B 0.00
Atrinsic (PTIX) United States $0.002B 0.00
Entero Therapeutics (ENTO) United States $0.002B 0.00
Silo Pharma (SILO) United States $0.002B 0.00
Aptevo Therapeutics (APVO) United States $0.002B 0.00
Revelation Biosciences (REVB) United States $0.001B 0.00
Capstone Therapeutics (CAPS) United States $0.000B 0.00
TFF Pharmaceuticals (TFFP) United States $0.000B 0.00
NuCana (NCNA) United Kingdom $0.000B 0.00
Aceragen (ACGN) United States $0.000B 0.00
ARAVIVE, INC (ARAV) United States $0.000B 0.00
Clovis Oncology (CLVSQ) United States $0.000B 0.00
Cocrystal Pharma (COCP) United States $0.000B 0.00
Celyad SA (CYAD) Belgium $0.000B 0.00
CytoMed Therapeutics (GDTC) Singapore $0.000B 0.00
Galapagos (GLPG) Belgium $0.000B 0.00
Motif Bio Plc (MTFB) United Kingdom $0.000B 0.00
PDL BioPharma (PDLI) United States $0.000B 0.00
Pulmatrix (PULM) United States $0.000B 0.00
VectivBio Holding AG (VECT) Switzerland $0.000B 0.00